Terameprocol Inhibits Inflammation
Author Information
Author(s): Dawn Eads, Rebecca Hansen, Bola Oyegunwa, Chad Cecil, Caril Culver, Frank Scholle, Timothy Petty, Scott Laster
Primary Institution: North Carolina State University
Hypothesis
Does terameprocol display anti-inflammatory activity?
Conclusion
Terameprocol inhibited the production of inflammatory lipids and several key cytokines, suggesting its potential as a treatment for inflammatory disorders.
Supporting Evidence
- Terameprocol significantly inhibited the production of prostaglandins in RAW 264.7 cells.
- Terameprocol reduced levels of COX-2 mRNA and protein.
- Terameprocol inhibited the production of TNF-α and MCP-1 in vivo.
- Terameprocol's effects were consistent across different inflammatory stimuli.
Takeaway
Terameprocol is a compound that can help reduce inflammation in the body by stopping the production of certain harmful substances.
Methodology
The study used RAW 264.7 cells and C57BL6/J mice to test the effects of terameprocol on inflammatory responses induced by LPS.
Potential Biases
Potential bias due to funding from a pharmaceutical company that produces terameprocol.
Limitations
The study primarily focused on in vitro and in vivo models, which may not fully represent human responses.
Participant Demographics
C57BL6/J mice, 6-8 weeks old.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website